MMS

Call Directions Website

MMS MMS is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach.

MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company has been recognized as a leading CRO in Global Health & Pharma’s international awards programs for three consecutive years.

How can we bring greater consistency to safety reporting for psychedelic and related therapies?At CNS Summit 2026 in Bos...
10/20/2026

How can we bring greater consistency to safety reporting for psychedelic and related therapies?

At CNS Summit 2026 in Boston, November 1–4, Amanda Beaster, PhD, Senior Director, Regulatory Strategy at MMS, will present research on standardized MedDRA coding and its role in supporting more consistent adverse event reporting, safety monitoring, and regulatory decision-making.

Amanda will be joined by Chris Schoonmaker, Chief Operating Officer, and Duane Robinson, Senior Director, Business Development.

Book a meeting with the MMS team at CNS Summit to learn more: https://hubs.li/Q04Bx-r40

We’re heading to Copenhagen for OCT Nordics!On October 20–21, 2026, Ben Dudley, President and Chief Commercial Officer, ...
10/19/2026

We’re heading to Copenhagen for OCT Nordics!

On October 20–21, 2026, Ben Dudley, President and Chief Commercial Officer, will be attending OCT Nordics, connecting with leaders from across the clinical research community.

Attending OCT Nordics? Connect with Ben to discuss biometrics, regulatory strategy, and data-driven approaches to clinical development, and explore how MMS can support your development priorities.

Book a meeting: https://hubs.li/Q04BxRqY0

FDA orphan drug designation can unlock major incentives but securing it takes more than meeting basic criteria.From indi...
10/19/2026

FDA orphan drug designation can unlock major incentives but securing it takes more than meeting basic criteria.

From indication strategy and prevalence estimates to scientific rationale and clinical superiority planning, successful orphan designation applications require careful alignment from the earliest stages of development.

Our latest blog explores the most common pitfalls sponsors face and shares practical considerations to help build a stronger regulatory strategy from the outset.

Click here to learn why early planning is critical for long-term success: https://hubs.li/Q04BplWc0

We’re heading to Utrecht, Netherlands, for the TOPRA Annual Symposium!From October 19–21, 2026, Sal Siam, Director of Bu...
10/16/2026

We’re heading to Utrecht, Netherlands, for the TOPRA Annual Symposium!

From October 19–21, 2026, Sal Siam, Director of Business Development, will be joining regulatory professionals from across the industry to explore the latest developments, challenges, and opportunities shaping regulatory affairs.

If you’re attending, connect with Sal to discuss how MMS supports sponsors in navigating complex regulatory pathways and advancing development programs with confidence.

Book a meeting: https://hubs.li/Q04Bphwk0

7 weeks until the Citeline Scrip Awards ceremony at Raffles London at the OWO!MMS has been shortlisted for the Best CRO ...
10/15/2026

7 weeks until the Citeline Scrip Awards ceremony at Raffles London at the OWO!

MMS has been shortlisted for the Best CRO – Specialist Provider award. This recognition reflects 20 years of helping sponsors navigate complex development challenges through scientific rigor, regulatory expertise, biometrics excellence, and data-driven innovation. From accelerated pathways and global submissions to advanced biostatistics, analytics, and insights powered by Datacise® and KerusCloud®, we're committed to helping sponsors make better development decisions and bring therapies to patients faster.

Congratulations to our fellow finalists, we look forward to celebrating biopharma excellence with you.

Click here to learn more: https://hubs.li/Q04zqGMq0

Safety Review Committees (SRCs) and Data Monitoring Committees (DMCs) are making increasingly complex decisions, yet man...
10/14/2026

Safety Review Committees (SRCs) and Data Monitoring Committees (DMCs) are making increasingly complex decisions, yet many review processes still rely on static reports that can limit insight and slow decision-making. In this webinar, MMS experts will explore how interactive safety visualizations can help reviewers investigate emerging signals in real time, access participant-level data, and make more informed safety decisions.

Register today to join an insightful discussion with Chris Schoonmaker, Chief Operating Officer, Kris Wenzel, Director, Data Science, and Andrew Mills, Strategic Principal Statistician: https://hubs.li/Q04B5NkL0

As regulatory expectations evolve, sponsors face a critical challenge: how do you protect patient privacy while preservi...
10/12/2026

As regulatory expectations evolve, sponsors face a critical challenge: how do you protect patient privacy while preserving the scientific value of clinical data?

In this blog, Brittany Wright, PhD, Clinical Trial Transparency Specialist, MMS, and Himanshu Kumar Singh, Senior Business Development Manager, TrialAssure, explore how AI-powered anonymization can support compliance, reduce manual effort, and help sponsors maintain the integrity and usefulness of their clinical data.

Read more: https://hubs.li/Q04zzjBs0

Safety Review Committees (SRCs) and Data Monitoring Committees (DMCs) are making increasingly complex decisions, yet man...
10/09/2026

Safety Review Committees (SRCs) and Data Monitoring Committees (DMCs) are making increasingly complex decisions, yet many review processes still rely on static reports that can limit insight and slow decision-making. In this webinar, MMS experts will explore how interactive safety visualizations can help reviewers investigate emerging signals in real time, access participant-level data, and make more informed safety decisions.

Register today to join an insightful discussion with Chris Schoonmaker, Chief Operating Officer, Kris Wenzel, Director, Data Science, and Andrew Mills, Strategic Principal Statistician: https://hubs.li/Q04z70lg0

AI is giving small and mid-sized biotechs access to capabilities that were once out of reach, but success won't come fro...
10/08/2026

AI is giving small and mid-sized biotechs access to capabilities that were once out of reach, but success won't come from technology alone. The organizations that gain a competitive edge will be the ones that use AI to make better development, clinical, statistical, and regulatory decisions. Learn why smarter decision-making, not just faster processes, will define the next generation of biotech success in our latest blog from Irving Dark, Member of MMS Board of Directors, and Aiden Flynn, Senior Vice President, Strategic Statistical Services.

Read the blog: https://hubs.li/Q04zqjDv0

Great science deserves clear, strategic communication. At MMS, our medical writers play a critical role in helping innov...
10/07/2026

Great science deserves clear, strategic communication. At MMS, our medical writers play a critical role in helping innovative therapies move through development and toward patients.

We're expanding our global Medical Writing team and are hiring for multiple remote positions across the US, UK, and Canada, including:
- Senior Manager, Regulatory & Medical Writing (US & UK)
- Principal Medical Writer (UK)
- Senior Medical Writer (US & Canada)
- Senior Nonclinical Writer (Canada)

If you're passionate about scientific excellence, strategic thinking, and partnering with sponsors on complex development programs, we'd love to hear from you.

Explore our open opportunities and help shape the future of clinical development with a team recognized for expertise, collaboration, and innovation: https://hubs.li/Q04z6Yq_0

Address

6880 Commerce Boulevard
Canton, MI
48187

Telephone

+17342450310

Website

Alerts

Be the first to know and let us send you an email when MMS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category